Testing Molecular Therapies in Hepatocellular Carcinoma: The Need for Randomized Phase II Trials-Reference-Cited by-同舟云学术

Testing Molecular Therapies in Hepatocellular Carcinoma: The Need for Randomized Phase II Trials

Published:2009-02-20 Issue:6 Volume:27 Page:833-835
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Llovet Josep M.¹,Bruix Jordi²

Affiliation:

1. Mount Sinai Liver Cancer Program, Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY; Barcelona Clinic Liver Cancer Group, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Hospital Clinic; and Institució Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain

2. Barcelona Clinic Liver Cancer Group, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Hospital Clinic, Barcelona, Catalonia, Spain

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.19.1973

Reference16 articles.

1. Global Cancer Statistics, 2002

2. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆

3. Rising Incidence of Hepatocellular Carcinoma in the United States

4. Sorafenib in Advanced Hepatocellular Carcinoma

5. Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pericytes in the Gut;Advances in Experimental Medicine and Biology;2019

2. Overexpression of epithelial cell adhesion molecule as a predictor of poor outcome in patients with hepatocellular carcinoma;Experimental and Therapeutic Medicine;2018-09-26

3. Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight;Cancer Cell International;2018-03-20

4. FGF8 promotes cell proliferation and resistance to EGFR inhibitors via upregulation of EGFR in human hepatocellular carcinoma cells;Oncology Reports;2017-04

5. Gastroesophageal Varices;Liver Pathophysiology;2017